NEW YORK (GenomeWeb News) – NextBio said today that the Cancer Care Institute will use its software under a strategic collaboration to interpret genomic data from cancer patients.
Under the partnership, CCI, which has campuses in San Jose and Morgan Hill, Calif., will apply the NextBio software platform to analyze patients' genomic data and streamline the use of that information in the clinic.
CCI "cares for a very diverse group of patients of many different races and ethnicities, so we often see findings and trends that are not captured in the literature," Morteza Dowlatshahi, CCI's medical director, said in a statement.
Dowlatshahi said the software provides an "easy-to-use way to interpret our patients' genomic data to conduct research studies as well as to identify optimal treatments."
Alpana Verma-Alag, head of clinical development at NextBio, said that using tools for handling large-scale data handling technologies enables the company to "meaningfully interpret the molecular data from a person in a short amount of time, which has phenomenal implications for translational research and patient care."